An Overview on Cancer Diagnosis based on Antibody-Based Immune Techniques
- سال انتشار: 1399
- محل انتشار: دوفصلنامه آزمایشگاه پزشکی مدرن، دوره: 3، شماره: 2
- کد COI اختصاصی: JR_MML-3-2_006
- زبان مقاله: انگلیسی
- تعداد مشاهده: 249
نویسندگان
Department of Biomedical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran
Department of Biomedical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran.
Department of Biomedical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran.
چکیده
Cancer is known as a second-high fatal disease after cardiovascular disease in the world. Although many techniques have been investigated for the treatment of cancer, none of them satisfied completely. Investigation of a cancer diagnosis is the new pathway to cancer therapy. It has been known that cancer diagnosis at its early stage could help eradicate it in the patientchr('۳۹')s body. Among different techniques that have been investigated for cancer diagnosis in its early stages, immune assay techniques due to high sensitivity and selectivity have been comprised. This review investigates new immune assay techniques and their combination with others as a new cancer diagnosis method.کلیدواژه ها
immunoassay, cancer diagnosis, antibody, microarray, antibody-based immune sensorsاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.